These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 29255545)

  • 1. HIV screening among TB patients and level of antiretroviral therapy and co-trimoxazole preventive therapy for TB/HIV patients in Hawassa University Referral Hospital: a five year retrospective study.
    Simieneh A; Hailemariam M; Amsalu A
    Pan Afr Med J; 2017; 28():75. PubMed ID: 29255545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evaluation of collaboration in the TB and HIV control programme in Oromia Region, Ethiopia: Seven years of retrospective data.
    Sisay S; Mekonen A; Abera A; Berhan Y; Kebede T; Ferede A
    Int J Infect Dis; 2018 Dec; 77():74-81. PubMed ID: 30336266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV screening among TB patients and co-trimoxazole preventive therapy for TB/HIV patients in Addis Ababa: facility based descriptive study.
    Denegetu AW; Dolamo BL
    PLoS One; 2014; 9(2):e86614. PubMed ID: 24498278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TB/HIV co-infections and associated factors among patients on directly observed treatment short course in Northeastern Ethiopia: a 4 years retrospective study.
    Mekonnen D; Derbie A; Desalegn E
    BMC Res Notes; 2015 Nov; 8():666. PubMed ID: 26559922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and predictors of mortality among children co-infected with tuberculosis and human immunodeficiency virus at public hospitals in Southern Ethiopia.
    Dawit Z; Abebe S; Dessu S; Mesele M; Sahile S; Ajema D
    PLoS One; 2021; 16(6):e0253449. PubMed ID: 34191846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberculosis incidence is high in HIV-infected African children but is reduced by co-trimoxazole and time on antiretroviral therapy.
    Crook AM; Turkova A; Musiime V; Bwakura-Dangarembizi M; Bakeera-Kitaka S; Nahirya-Ntege P; Thomason M; Mugyenyi P; Musoke P; Kekitiinwa A; Munderi P; Nathoo K; Prendergast AJ; Walker AS; Gibb DM;
    BMC Med; 2016 Mar; 14():50. PubMed ID: 27004529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment Outcome of Tuberculosis and Associated Factors among TB-HIV Co-Infected Patients at Public Hospitals of Harar Town, Eastern Ethiopia. A five-year retrospective study.
    Tola A; Mishore KM; Ayele Y; Mekuria AN; Legese N
    BMC Public Health; 2019 Dec; 19(1):1658. PubMed ID: 31822286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delivering TB/HIV services in Ghana: a comparative study of service delivery models.
    Ansa GA; Walley JD; Siddiqi K; Wei X
    Trans R Soc Trop Med Hyg; 2014 Sep; 108(9):560-7. PubMed ID: 25059522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the accessibility of HIV care packages among tuberculosis patients in the Northwest Region, Cameroon.
    Njozing NB; Miguel SS; Tih PM; Hurtig AK
    BMC Public Health; 2010 Mar; 10():129. PubMed ID: 20226022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence and associated factors for delayed presentation for HIV care among tuberculosis/HIV co-infected patients in Southwest Ethiopia: a retrospective observational cohort.
    Gesesew H; Tsehaineh B; Massa D; Tesfay A; Kahsay H; Mwanri L
    Infect Dis Poverty; 2016 Nov; 5(1):96. PubMed ID: 27802839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival and predictors of mortality among children co-infected with tuberculosis and human immunodeficiency virus at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia. A retrospective follow-up study.
    Atalell KA; Birhan Tebeje N; Ekubagewargies DT
    PLoS One; 2018; 13(5):e0197145. PubMed ID: 29787596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of lifetime survival and predictors of mortality among TB with HIV co-infected children after test and treat strategies launched in Northwest, Ethiopia, 2021; a multicentre historical follow-up study.
    Chanie ES; Gelaye GA; Tadesse TY; Feleke DG; Admas WT; Molla Alemu E; Azanaw MM; Tiruneh SA; Gebremariam AD; Birhane BM; Bayih WA; Aragie G
    PLoS One; 2021; 16(12):e0258964. PubMed ID: 34932563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mortality review of tuberculosis and HIV co-infected patients in Mahalapye, Botswana: Does cotrimoxazole preventive therapy and/or antiretroviral therapy protect against death?
    Tshitenge S; Ogunbanjo GA; Citeya A
    Afr J Prim Health Care Fam Med; 2018 Nov; 10(1):e1-e5. PubMed ID: 30456967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and predictors of LTFU among adults with TB/HIV co-infection in two governmental hospitals, Mekelle, Ethiopia, 2009-2016: survival model approach.
    Gezae KE; Abebe HT; Gebretsadik LG
    BMC Infect Dis; 2019 Feb; 19(1):107. PubMed ID: 30717705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful TB treatment outcome and its associated factors among TB/HIV co-infected patients attending Gondar University Referral Hospital, Northwest Ethiopia: an institution based cross-sectional study.
    Sinshaw Y; Alemu S; Fekadu A; Gizachew M
    BMC Infect Dis; 2017 Feb; 17(1):132. PubMed ID: 28178936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of mortality among TB-HIV Co-infected patients being treated for tuberculosis in Northwest Ethiopia: a retrospective cohort study.
    Sileshi B; Deyessa N; Girma B; Melese M; Suarez P
    BMC Infect Dis; 2013 Jul; 13():297. PubMed ID: 23815342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T lymphocyte subpopulations and intestinal helminthes profile among tuberculosis patients co-infected with HIV before and after anti tubercular treatment at University of Gondar Hospital, Northwest Ethiopia.
    Wondmagegn T; Damtie D; Genetu M; Biadgo B; Lemma M; Negash M
    BMC Infect Dis; 2020 Feb; 20(1):109. PubMed ID: 32033581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of human immunodeficiency virus infection in a cohort of tuberculosis patients at Metema Hospital, Northwest Ethiopia: a 3 years retrospective study.
    Tarekegne D; Jemal M; Atanaw T; Ebabu A; Endris M; Moges F; Tessema B; Deressa T
    BMC Res Notes; 2016 Mar; 9():192. PubMed ID: 27026410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. National scale-up of tuberculosis-human immunodeficiency virus collaborative activities in Myanmar from 2005 to 2016 and tuberculosis treatment outcomes for patients with human immunodeficiency virus-positive tuberculosis in the Mandalay Region in 2015.
    Theingi P; Harries AD; Wai KT; Shewade HD; Saw S; Win T; Thein S; Kyi MS; Nyunt Oo H; Aung ST
    Trans R Soc Trop Med Hyg; 2017 Sep; 111(9):402-409. PubMed ID: 29361150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immunodeficiency virus-associated tuberculosis care in Botswana: evidence from a real-world setting.
    Muyaya LM; Musanda EM; Tamuzi JL
    BMC Infect Dis; 2019 Sep; 19(1):767. PubMed ID: 31477055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.